Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is Rocket Lab’s Stock Undervalued?

Published 08/10/2022, 12:29 AM
Updated 07/09/2023, 06:31 AM

In comparison with perceived market-leader SpaceX, Rocket Lab USA's (NASDAQ:RKLB) valuation is underwhelming. Given its $2.5 billion market capitalization, Rocket Lab is eclipsed by the $127 billion SpaceX. However, analysts believe that assessing Rocket Lab's true worth warrants a look beyond its immediate financial results and into pieces it is adding to the game.

Looking beyond valuations, Rocket Lab had been operating at a loss for at least the last 12 months. Despite this, its shares grew 26% over the last month. It hit $5.55 on Aug. 4 when it launched a US spy satellite in New Zealand atop its Electron booster. It reached another high on Aug. 8 at $5.60 before closing the day at $5.45.

From a more macro point of view, Rocket Lab’s stock price is traveling in line with other SPAC listings, down 55% for the year-to-date, which opens the question as to why it is not more in line with defense stocks, such as iShares US Aerospace & Defense ETF (NYSE:ITA) (up 1.73% YTD), which appear to be benefiting from the increase in US defense spending.

RKLB daily chart with iShares U.S. Aerospace & Defense ETF.

Bearish Second-Quarter Forecast

Rocket Lab is set to announce its results for the quarter ended Jun. 30 on Aug. 11. It expects EBITDA loss to be between $3.5 million and $5.5 million and for its revenue to be somewhere within the $51 million to $54 million range. The company is expected to record a normalized loss per share of $0.06.

In the first quarter of 2022, the company recorded an adjusted loss of roughly $8.0 million and a 124% year-over-year hike in revenue to $40.7 million. Despite the bearish expectations for the upcoming results, it can be observed that the loss Rocket Lab has been reporting has become less than in the previous period. The company may not be far from breaking even at the rate it is going.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Retaining Confidence

The Aug. 4/5 launch for the US National Reconnaissance Office boosted the company's confidence, enough to lift its stocks to $5.55. The mission marked the 146th satellite deployment from the Electron booster to date. But as noted above, Rocket Lab may not have experienced the full impact of the increase in US defense spending.

Additionally, the company is currently developing Neutron, a reusable booster planned to be 40 meters high and have a 7-meter diameter. It is a medium-lift rocket designed to deploy mega-constellations, human spaceflight, and deep space missions. The first flight of Neutron is planned for 2024.

The reusable aspect of the Neutron could be a make-or-break product for Rocket Lab. If successful, the reusable Neutron can carry out more launches and generate more revenue over a definite period. It can eventually lead to better gross profits as it will help reduce production costs.

In this respect, Rocket Lab may offer an asymmetric risk/reward at the current valuation due to potential profitability gains through diversification and with attempts to reuse the Electron booster.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.